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ABSTRACT
The increased popularity ofalternative medicine treatments has prompted
resurgence in the use of traditional herbal remedies. Among this vast number ofherbs,
ginseng is purchased by a considerable number ofconsumers; especially three species:
Panax ginseng, Panax quinquefolium, and Eleutherococcus senticosus. Many of the
physiological effects claimed by ginseng manufacturers tend to mimic those of central
nervous system stimulants. This led to the purpose of this research, which was to
develop an HPLC chromatographic method in order to determine if any specific CNS
stimulants are within ginseng supplements. Specifically we found a series ofCNS
stimulants, methylxanthines (caffeine, theophylline, and theobromine), do exist in
varying concentrations. The identity and concentration of the specific methylxanthines
varied with the type ofginseng and the manufacturer.
The final conditions for the efficient chromatographic separation are through the
use ofa Hewlett-PackardModel 1 100 HPLC with a Zorbax C18-SB column, a mobile
phase composition of21% methanol: 79% (2%) acetic acid, a column temperature of
35C, a flow rate of 1.0 ml/min, and a UV wavelength detection at 280 nm. The levels of
methylxanthines ranged from 0-1 mg/dose to 15-50 mg/dose. Identification of the
methylxanthines was confirmed via standard addition, GC-MS and/or LC-MS.
vm
I. INTRODUCTION
Holistic medicines, homeopathic remedies and dietary supplements are the current
catch phrases important to the burgeoning area ofalternative medicine therapy. Many
people disillusioned with the complexities ofmodern medicine are looking for alternatives to
their HMO and primary care physician. Many of these individuals are utilizing a whole
series ofdifferent
"medications"
that can best be described asphytopharmaceuticals.
Phytopharmaceuticals are supplements derived frommedicinal plants and herbs that are
meant to be ingested. Hundreds of these herbal compositions are available to the
consumer and promise to maintain good health as well as improve performance in literally
all aspects of life from libido lifts to stress relief to carcinoma cures. Many of these claims
are based on anecdotal or cultural histories where the herbs have been used for centuries
as medicines and remedies. While many individuals claim that the phytopharmaceuticals
are the wonder drugs of the 90's, many of the physical effects are scientifically
unsubstantiated. This is not to say that herbs cannot be potent medications, many modern
day medicines are derived from herbal extracts. In 1994, the Dietary Supplement Health
and Education Act (DSHEA) removed dietary supplements from the FDA's food additive
category shifting the burden ofproof to the FDA to prove lack of safety rather than falling
on the supplement manufacturer to prove
safety.1'2
Since the FDA does not regulate
phytopharmaceuticals for their quality or composition, animal studies are not required for
the determination of safety and there are no set requirements for dosage or composition of
the supplements. In most cases, the complete chemical composition of these compounds
is not even known. Finally, the few clinical and chemical studies associated with many of
these products are typically contradictory and/or
inconclusive.3
For instance, studies on
the effects ofginseng on stress with rats has shown that a daily dose does indeed reduce
stress levels in rats, however studies with human subjects are inconclusive with regards to
any substantial physiological
effect.4,5
It is interesting that long term exposure to ginseng
can cause several side effects including: blood pressure fluctuations, nervousness,
insomnia, heart palpitations, anxiety, and
dermatitis.3
Therefore, documentation ofthe
physiological benefits or dangers ofphytopharmaceuticals is a definite need for the
consumer. Consequently, a chemical characterization and quantification of the basic
components within many of these products is a real and critical need. We have chosen to
exclusively focus this research on the characterization ofa single supplement of
widespread use, ginseng.
Ginseng has been used for nearly 5000 years as a mainstay ofChinese medicine.
The earliest mention of the use ofginseng is in the 2000 year old herbal ofSeng
Nong.6
Ginseng is claimed to be a cure-all panacea, an aphrodisiac and an adaptogen (producer of
a state of increased resistance to body stress). There are three common species of
ginseng: 1) Asian Ginseng {Panaxpseudoginseng Wallichs); 2) American Ginseng (Panax
quinquefolius L.); 3) Siberian Ginseng (Eleutherococcus senticosus) (Figure 1). Ginseng
preparations are derived from the dried root of two species of the Araliaceae family,
Panax ginseng C.A. Mey (Chinese ginseng) which is native to the northeastern region of
China and Panax quinquefolium L. (American ginseng) which is native to northeastern
North
America.6'7
The Latin name Panax means
"panacea"
or all-healing. These plants
are now rare in nature after years ofover-collection and are now considered endangered






species. Currently, most preparations ofginseng are derived from cultivated plants,
however tradition indicates that wild plants will be more effective. Another ginseng
product, Siberian ginseng, is derived from Eleutherococcus senticosus a plant also from
the ivy family (Araliaceae) found in Russia. This closely related plant seems to produce
the same physiological effects as
Panax6
Ginseng samples typically contain numerous compounds. These include ginseng
saponins, ginseng oil, phytosterol, sugars, carbohydrates, acids, nitrogenous substances,
amino acids, peptides, vitamins, minerals, ferments, and enzymes. Among these, it is
assumed that ginseng saponins contribute the most, ifnot all, of the claimed
pharmacological activities ofginseng extract
preparations.5'8"21
Therefore,
analysis ofginseng products has centered on the isolation and determination of the
concentrations of the various saponin (sapogenin) glycosides within the herb.
Saponins are adducts ofa sugar (glucose, fructose, galactose, etc.) and a steroid or
terpene (Figure 2). The saponins are mainly ofplant origin, but also occur in a number of
marine animals. Saponins are chemically diverse compounds that have a particular set of
chemical properties, including formation ofcolloidal solutions in water, bitter taste,
sternutatory and irritant properties to the mucous membrane and hemolytic action against
red blood cells. Althoughmost saponins are non-toxic and appear to have no deleterious
physiological effects, very high doses of saponins can cause intestinal irritations and
lesions. While further information about saponins is of interest, they do not explain many
ofthe traditional effects claimed by ginseng users. The amount of saponins





Ginsenoside Rg] H Glc-O- Glc-
Ginsenoside Rg2 H Rha-Glc-O- H
Ginsenoside Re H Rha-Glc-O- Glc-
Ginsenoside Rf H Glc-Glc-O- H
Ginsenoside Rh,. H Glc-O- H
Ginsenoside Rb! Glc-Glc- H Glc-Glc-
Ginsenoside Rt>2 Glc-Glc- H Ara(p)-Glc-
Ginsenoside Re Glc-Glc- H Xyl-Glc-
Ginsenoside Rd Glc-Glc- H Ara(f)-Glc-
Ginsenoside Rg3 Glc-Glc- H H
Glc- Glucose, Rha- Rhamnose, Ara- Arabinose, Xyl- Xylose
within ginseng have been analyzed using several techniques although the most traditional
method is reverse phase high performance liquid chromatography,
HPLC.8"13
Components
are identified by comparison to retention times ofginsenoside standards. The goal of this
study is to chromatographically determine the identity of chemical complexes, other than
the saponins, within the various types ofginseng materials. Specifically, analysis will
focus on the determination of the concentration levels ofmethylxanthines (stimulants)
within ginseng
plants.22"24
Methylxanthines are well known for their stimulatory effects on the central nervous
system and cardiovascular system. This is probably the reason that plant extracts such as
coffee, tea, and chocolate have been used for centuries. Unlike other secondary products
produced uniquely by only one plant species, methylxanthines appears to be a widespread
secondary product found in a variety ofunrelated plant
species.25
There are numerous
methylxanthines, however, we will focus on the most abundant: theobromine,
theophylline, and
caffeine26"28
(Figure 3). The threshold of stimulation is quite different for
eachmethylxanthine as seen in Table 1
Theobromine (3,7-dimethylxanthine) is an alkaloid generally found in cocoa beans
and hence chocolate. It is the least active as a central nervous stimulant of the three
naturally occurring methylxanthines. It was used for the treatment ofasthma, as a cardiac
stimulant, as a diuretic, and in veterinary medicine as a
vasodilator.27'28
Theophylline (1,3-dimethylxanthine) is an alkaloid found in plants such as the
leaves of the tea bush. It is primarily used as a drug for the treatment ofasthma. The
major pharmacological actions of theophylline include stimulation of the cardiac muscle



















Table 1. Comparison of thresholds of stimulation by the most abundant methylxanthines.
METHYLXANTHINES Threshold ofStimulation C^mol/kg')
Theophylline ( 1 ,3 -Dimethylxanthine) 1 0
Caffeine ( 1 ,3 ,7-Trimethylxanthine) 25
Theobromine (3,7-Dimethylxanthine) 250
causing more complete emptying of the heart; relaxation of the bronchial muscle; acting as
a diuretic increasing urine output and stimulation ofthe central nervous system.
The metabolism of theophylline has been extensively studied. Approximately 10% is
excreted unchanged in the urine while the remaining 90% of the drug is converted to other
compounds before it is eliminated from the body. The biologic half-life of theophylline
varies from 3.5 hours in children to 8-9 hours inmost adults. It is substantially prolonged
in the presence of liver disease and/or cardiac decompensation. The amount of
theophylline required to produce the desired benefits is 10-20 ug/ml with toxic side effects
common at levels above 20 pg/ml. The toxic effects on the central nervous system are
evident as wakefulness, restlessness, and agitation. These symptoms may progress to
seizures, coma and death. The toxic effects on the myocardium consist of increased heart
rate and cardiac
arrhythmia.27'28
Caffeine (1,3,7-trimethylxanthine) is a naturally occurring substance found in the
leaves, seeds or fruits ofmore than 60 plants including coffee beans, cocoa beans, kola
nuts and tea leaves. These products are commonly used to make many favorite beverages
such as coffee, tea and cola drinks, and foods such as chocolate. People differ greatly in
their innate sensitivity to caffeine. Many individuals can drink several cups ofcoffee
within an hour and notice no effects, others may feel some effect after one
serving.29"32
Caffeine does not accumulate in the bloodstream or body and is normally excreted within
several hours following consumption.
The determination ofmethylxanthines in various ginseng supplements will be
analyzed via reverse phase HPLC. While the initial conditions for HPLC stem from
AOAC OfficialMethod, Theobromine and Caffeine in Cacao Products22, further methods
development to improve the procedure will be studied. Other analyses will include GC-
MS, UV-Vis, and LC-MS of the supplements for further assurance of the presence ofone
or more methylxanthine.
A. CHROMATOGRAPHIC THEORY
High Performance Liquid Chromatography, HPLC, is one of the prevalent
analytical separation tools used for medical, industrial and academic applications. By
definition, HPLC comprises all liquid chromatographic techniques that require the use of
elevated pressures to force the liquid through a packed bed of the stationary phase.
Through a series of chemical and physical interactions, materials can be separated into less
complex mixtures and matrices. After purification either interfaced or external processes
can be used to complete the characterization.
During the 1960's, gas, column and thin layer chromatography were the main
instruments for separation science. The need for a chromatographic technique suitable for
the routine and fast analysis ofnon-volatile compounds was essential for many different
types of industrial applications. The application ofchromatographic theory to the
development ofcolumn liquid chromatography led to the use ofvery small particles for the
solid adsorbent stationary phase. The advent of efficient packing technology in the 1970's
made it feasible to reproducibly prepare high-efficiencyHPLC columns from 5 to 10-um
particles. Prior to this development, packing techniques had failed to give good results for
particles smaller than about 30 pm The termHPLC was first defined as High Pressure
Liquid Chromatography in relevance to the need of sufficient pressure to produce a more
rapid flow rate in correlation to the low permeability ofthe packing material at that time.
Soon this name was replaced by High Performance Liquid Chromatography corresponding
to the new instrumental technique having better
"performance"
in terms of resolving
power, detection, quantification and speed.
There exist several types ofchromatography with the most traditional form of
liquid chromatography referred to as normal-phase chromatography. It involves a polar
adsorbent such as silica or alumina and a nonpolar mobile phase. The mechanism for
separation consists of the interaction of the polar functional groups of the analytes with
polar sites of the packing.
Reversed-phase chromatography developed in the late 70's, involves a nonpolar
stationary phase, typically silica-based, and a polar, usually aqueous, mobile phase.
Although the separation mechanisms in reverse phase chromatography are still under
discussion, basic retention is a function of the hydrophobicity of the analyte. In turn, the
hydrophobicity ofthe analyte is a direct function of the size of the hydrophobic area ofa
molecule. Therefore, reversed-phase chromatography is ideal for the separation of
compounds ofa homologous series. For instance, not only can similar analytes be
separated by reversed-phase chromatography but at times, it is also possible to assign the
order ofelution based on their structures. Another advantage of reversed phase HPLC is
that equilibration of the columns with the aqueous mobile phases is rapid; in most cases
only a few column volumes are needed. For the majority ofanalytes, good peak shapes
and reproducible retention times are obtained without difficulty. Reverse phase
chromatography is by far the most popular HPLC technique.
An HPLC system consists of 8 major components: (1) the mobile phase reservoir;
(2) the pump, (3) the injector/autosampler, (4) the column, (5) the detector; (6) the data
10
system, (7) the connective tubing, and (8) the waste reservoir (Figure 4). Each
component has a specific function. The mobile phase transports the analyte to the column
and must be degassed/ filtered to keep the system free of insoluble particulates that could
clog tubing. The pump is capable ofdelivering pulse-free flow at pressures up to 6000
psi. The type and length ofcolumn vary according to the separation procedure of interest.
The detector must give a linear response to the solute of interest over the range of
concentrations to be analyzed. The data system simply handles the signal that is generated
from the detector. Finally, the connective tubing must ensure zero volume, which is
essential to minimize dead volumes, band broadening and enhance resolution




In order to understand the applications and terminology ofHPLC, the basic
fundamentals must be thoroughly understood. The following is a list ofessential
definitions to the chromatographer in understanding the applications ofHPLC.
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Elution Volume and Peak Width:
Elution volume and peak widths are the two basic measurements required
to develop the theory and definitions ofHPLC.
Figure 5. Representative chromatogram.
where V0 is the elution volume ofunretained compound which equals one column volume,
Vi is the elution volume ofcompound 1, V2 is the elution volume of compound 2, and W2
is the peak width ofcompound 2 in terms ofvolume.
Isocratic Elution:
Isocratic elution indicates a constant solvent composition at a constant
temperature.
Gradient Elution:
Gradient elution refers to varying one or more parameters continuously. Typically,
only one parameter is varied. The type ofgradient that is used most often is mobile phase
composition from low elution strength to high elution strength. Elution strength is a
measure of the ability of the mobile phase to elute more strongly adsorbed solutes from
the column.
Temperature gradient:
Temperature gradient refers to varying the temperature in order to aid separation.
Usually the gradient goes from low temperature to high temperature to improve




Peak fronting occurs when too much sample has been applied to the column. The
excess solute affects the physical properties of the stationary phase and alters the
partitioning from the mobile to stationary phase. This
"overloading"
ofthe column results
in a gradual rise and an abrupt end of the chromatographic peak.







Peak tailing occurs when small quantities of solute are retained more strongly than
most ofthe solute. It leads to an abrupt rise and a long tail of the chromatographic peak.
A cause oftailing may be due to the presence ofof sites at which the solute is held
strongly by the stationary phase.







The more time the solute spends on the column the longer it will take to elute.
This results in a broad peak. To minimize band broadening from occurring outside the




Asymmetry factors are used to measure the tailing ofthe peaks. The factors may
be calculated in several different ways.
Figure 8. Chromatogram showing an asymmetric peak.
(1)
where B is the width of the tail of the peak and A is the width of the front
of the same peak.
Void volume (V0):
Void volume represents the total volume of the liquid retained within the column.
Linear flow rate:
The linear flow rate (px) refers to the distance, usually in cm, ofcolumn length
traveled in one minute by the solvent.
Retention Relationships
Retention time (tr):
Retention time is the time it takes the solute from injection onto the column until
that component reaches the detector.
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Time spent in mobile phase (tra):
tm is the time needed for the mobile phase to travel the length of the column. An
unretained solute would br eluted in time tm.
Volume Flow Rate (F):
Volume flow rate is the number ofmilliliters of solvent per minute that travel
through the column.
Retention Volume (Vr):
Retention time is the volume ofmobile phase required to elute a particular solute
from the column. This can be related to retention time and volume flow rate by
equation 2.
Vr = tr*F (2)
Capacity Factor (k'):
(a measure ofretention)
The capacity factor is a direct measure ofhow strongly a sample adsorbs to the
packing material of the column. The longer a component is retained by the column, the
greater the capacity factor. Large capacity factors favor good separation but also increase





Plate theory is described as the idea that the column is divided into N
Segments. Within each
"segment"
an equilibration occurs. In order to measure the









where tr is the retention time ofthe peak and w is the width of the band.
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Particle size:
Generally the smaller the particle size the more efficient the column Smaller
particles give more theoretical plates per length ofcolumn.
Height Equivalent to a Theoretical Plate (H.E.T.P.):
Injection ofa small volume ofanalytes onto a column results in a narrow band on
the top ofthe column The band becomes broader as the analyte migrates through the
column In a uniform bed, the peak width increases with the square root of the length that
the band has traveled.
Ifa mixture oftwo components is injected, they will both form the same narrow
band on top ofthe column Ifthey have slightly different affinities to the column, they will
migrate down the column at slightly different speeds. As they migrate down the column,
the distance between the centers ofboth bands increases in direct proportion to length that
the bands have traveled. In addition, the width ofeach band increases only with the
square root of this length. Thus, the bands will at some point be completely separated.
The farther theymigrate, the more resolved they would be.
35
H.E.T.P. = L/N (5)
where L is the total length of the column and N is the theoretical plates of the column.
Reduced Plate Height fh):
It is the comparison ofdifferent length columns that are also packed with different
sized particles.
h = H/dp (6)
where H is an abbreviation for HETP and dp is the diameter ofthe particles.
Theoretical plates can be controlled by many factors however; the most important one
is flowrate.
Figure 9. Plates vs. Flowrate
15




The van Deemter equation describes the dependence of the Height Equivalence of
a Theoretical Plate, HETP, on linear velocity. It assumes that the HETP is composed of
three different, independent contributions. These contributions are independent to one
another and thus form the observed curvilinear equation.
H = A + (B/p) + Cp (u
= linear velocity) (7)
where A, B, and C are constants for a given column and mobile phase. The A term
represents the multiple paths ofdifferent lengths possibly traveled by the solute. The B
term is inversely proportional to the linear velocity and it signifies longitudinal diffusion of
a solute as it travels through the column. The C term is directly proportional to the linear




This is the rate at which the mobile phase passes through the column. It can
sometimes be defined as linear flow rate or as volume flow rate because each is




(a measure ofpeak separation)
Selectivity is a measure ofpeak separation and describes how differently two
compounds react in the same chromatographic system.
a
= V? - Vn (8)
V.-Vo
where Vi and V2 are the elution volumes ofcompounds 1 and 2 respectively and V0 is the
volume of an unretained solute, which equals one column volume.
Resolution (Rs):
(Degree ofMagnitude ofSeparation)
Resolution is defined as the separation between two peaks. Two peaks are
assumed to be completely resolved when the resolution is equal to 1.5.
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Table 2. % Overlap between two peaks at various resolution values.






However, it can be shown that the resolution is given by:
(9)
R.= N (a-l/a)(k'/l+k') (10)
4
where N is the number oftheoretical plates, a is the relative retention,
k'
is the capacity
factor of the component of interest.


















increases, resolution increases until kV k'+l approaches a value of one.
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When the selectivity value is small, small changes in selectivity produce large changes in
resolution. The selectivity term approaches one when alpha is large.
Resolution depends on theoretical plates (N)
Table 4.
N, PLATE COUNT (N) RESULTS % CHANGE
N=1000 31.6
N = 2000 44.7 T41%
N = 3000 54.7 t 73%
N = 5000 70.7
N= 10,000 100 t 41%
N= 15,000 122.4 t 73%
Resolution increases proportionally with the square root of the theoretical plates (refer to
equation 7).
HPLC Methods Development
In carrying out quantitative analysis in a set of samples, it is necessary to develop a
protocol suitable for a specific separation. First, the separation problem must be defined
and all information essential to the problem is collected. Typically this would include:
- details ofthe physiochemical properties of the analyte;
- the physiochemical properties of the other components in the matrix;
features (desirable and undesirable) of the available methods for separation.
Major aspects ofmethod development include chromatographic expertise in which
the researcher needs to have as many potential solutions to the problem as possible at
his/her disposal. Optimization involves manipulation ofexperimental variables relating to




Specificity: An assay is specific if the analytical response arises from the analyte of interest
only and no other compound that may be in the sample can have the same response.
Linearity: Amethod is linear if there is a linear relationship between the analytical
response and concentrations ofanalyte in the sample solutions over a specified range of
concentration of the analyte.
Robustness: A robust or rugged method is one, which is not greatly affected by minor
changes that might reasonably be expected during the course ofan assay.
Precision: the precision ofamethod is the degree of scatter of the results and is usually
reported as a relative standard deviation. It is often subdivided into repeatability and
reproducibility.
Accuracy: An assay is accurate if the mean result from the assay is the same as the true
value.
Limit ofdetection: The limit ofdetection is the amount ofanalyte, which can be reliably
detected under the stated experimental conditions.
Limit ofquantitation: The limit ofquantitation is the amount ofanalyte, which can be
reliably quantified under the stated experimental conditions.
Stability in solution: It is important for the analyte to be sufficiently stable in solution in
the solvent used in order to carry out reliable analysis.
System suitability: It is important to know if the chromatographic technique of choice is
efficient for the methods development of the compound of interest.
20

























In this research project, methods development was accomplished by varying many
parameters ofthe HPLC instrument. Initial parameter changing will begin with mobile
phase composition. Once a good separation is established other parameters can be varied
such as column type, flow rate, column temperature, UV wavelength detection, volume of
sample injected, and concentration of the sample. A briefexample ofmethods
development is described in the following text.
Compound X is only known structurally. The assignment is to obtain peak purity
ofcompound X via HPLC. This can be done in the following way: first a literature search
is established on the compound itselfas well as on a similar compound. With this an initial
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protocol may be determined and can be applied to compound X. It is from this point that
parameters can be varied in order to obtain the best separation. Mobile phase composition
is usually the starting point; generally the organic solvents are increased rather than the
aqueous solvents. The next factor considered could be column type. Simply changing
column length can drastically expand the separation of the compound from other
constituents that may be in the sample. Next flow rate can be increased or decreased
which allows you to see the effects this can cause on the separation. Usually a flow rate
of 1 .0 ml/min is sufficient. Column temperature can sometimes decrease retention time,
decrease resolution, and sharpen peaks. Finally, the maximum absorbance ofcompound X
can be determined via UV-vis, which in turn can then be transferred over to the HPLC and
then analysis ofcompound X is obtained with all the appropriate conditions. All these
variations and optimizations of the different parameters constitute methods development.
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II. EXPERIMENTAL SECTION
The experimental procedures can be broken down into three main elements;
obtaining samples, extraction and HPLC analysis (includes methods development).
Various samples ofginseng herbal supplements were purchased from several retail
stores in the Rochester, NY area. Several trips were conducted to obtain samples
manufactured from different manufacturer lots. Another set of samples was purchased
from Chinese apothecaries inNew York City and Hong Kong. These were nonprocessed
root samples. All materials remained sealed in their appropriate containers until analysis.
A total of40 unique ginseng supplements were obtained and analyzed.
Prior to HPLC analysis the methylxanthines were extracted from the bulk material
with a slight variation of the accepted procedure described by AOAC for the extraction of
methylxanthines from Cocoa
beans.22
In the case ofsolid samples, the contents of one
capsule ofthe ginseng supplement were removed from the capsule and weighed; the mass
was typically 500 mg. The sample was then ground in a mortar and pestle and the
resultant fine powder was placed in 10-25 ml ofHPLC-grade water (Baker Chemical
Co.), heated to boil in an 800-watt microwave oven (Sharp) and then sonicated for 5
minutes in a VWR Scientific Sonicator. The resultant heterogeneous solution was filtered
first through a 0.45 pm and then a 0.20 pm filter disk (Gelman Acrodisks). The samples
were then ready for HPLC analysis.
In the case of liquid samples, the neat samples were heated as described above to
facilitate dissolution of the methylxanthines. The resultant solution was then filtered and
prepared as above.
23
Both internal and external standards were used in the HPLC analysis. Each
standard was weighed and dissolved in hot HPLC grade water. The concentrations
ranged from 0.01-0.1 mg/ml (see Table 5). The solutions were then sonicated for 5
minutes and heated in amicrowave oven for an additional 45 seconds to ensure complete
dissolution of the solid standard compound. The solutions were filtered first through a
0.45 pm and subsequently through a 0.20 pm filter disk. The external standard solutions
were then ready for HPLC analysis. Note that the external standard solutions were
analyzed at the beginning and at the end ofeach analysis run. For internal standards the
following protocol was followed: 0.10 pi ofthe standard solution and 0.90 u.1 ofwater
were added to 1.0 ml total volume of the ginseng solution. The internal standard solution
was then analyzed as indicated above.





















HPLC columns were purchased from Burdick and Jackson, Phenomenex, and
Hewlett Packard. The B&J column was an Octadecyl; Cl 8 bonded type OD5 column.
The silica substrate had a particle size of 5 pm and a 4.6 mm x 25 cm configuration. The
Phenomenex column was a C8 Luna column with a particle size of 5 pm and a 4.6 mm x
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15 cm configuration. The HP Zorbax C18-SB column contained StableBond silica packed
under high-pressure slurry loading technique to give optimum column efficiency. The
silica substrate had a particle size of 5 pm and a porosity of 80 A. This column is a Cl 8
stable bond with 4.6 mm x 25 cm configurations.
Analysis was performed on a Hewlett Packard Model 1 100 liquid chromatograph
equipped with HP ChemStations software and a variable-wavelength detector. The final
set ofconditions used for complete analysis of all the ginseng supplements consisted of a
mobile phase composition of21% methanol: 79% (2%) acetic acid, a column temperature
of35C, a flow rate of 1 .0 ml/min, a UV wavelength of280 nm and an average pressure
of 1 50 atm. The column used for all analyses was the HP Zorbax Cl 8-SB. Injections of
all samples were performed manually or with the use of an autosampler with the injection
volumes set at 5 pi or 10 pi. Each sample was analyzed at least twice.
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III. RESULTS/DISCUSSION
Methods development involves a strategic approach to an analytical problem
through the use ofnumerous steps. First and foremost, before any analysis can be done,
any and all pertinent information about the compound(s) of interest must be gathered.
After the knowledge base is established an initial experimental protocol can be mapped
out. In this research project, information on the methylxanthines as well as ginseng was
obtained from the literature. Our initial protocol was obtained from a standard method for
the determination ofcaffeine and theobromine in cocoa
beans.22
This gave us the starting
conditions for the separation of the methylxanthine standards. Using the Burdick and
Jackson OD5 Octadecyl HPLC column, the conditions used for this initial attempt
consisted ofa mobile phase composition of65% methanol: 35%(1%) acetic acid, column
temperature of25C, flow rate of 1 .0 ml/min, and UV detection wavelength of254 nm.
Figure 12 is a chromatogram ofnumerous methylxanthines at a concentration of 0.1
mg/ml with the above parameters. As observed, some methylxanthines are not well
separated and some peaks are ill-defined; specifically the peaks at 7.337 and 7.609 minutes
show extensive overlap and the peaks at 2.894 and 7.609 minutes exhibit prominent peak
tailing. Therefore, an experimental approach to resolve the peaks by achieving better
separation while simultaneously improving peak shape is the first goal. After, several
different mobile phase compositions with the B&J column were tried with limited success,
Figures 13 and 14, it was decided that success could not be achieved with the B&J
column. There are several factors that need to be considered when choosing the right
column. Typically this involves column design features such as packing material, length,
26
Figure 12. Chromatogram ofvarious methylxanthine standards.


















HPLC analysis ofnumerous methylxanthines at a concentration of0.1 mg/ml with a
Burdick and Jackson column and HPLC conditions of65% methanol: 35% (1%) acetic
acid, flow rate of 1.0 ml/min, column temperature of25C and aUV wavelength of254
nm Compounds are as labeled.
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Figure 13. Chromatogram ofvarious methylxanthine standards.
HPLC analysis ofnumerous methylxanthines at a concentration of0.1 mg/ml with a
Burdick and Jackson column and HPLC conditions of90% acetonitrile: 10% (1%) acetic
acid, flow rate of 1.0 ml/min, column temperature of25C and a UV wavelength of254
nm Compounds are as labeled.
Figure 14. Chromatogram ofvarious methylxanthine standards.
HPLC analysis ofnumerous methylxanthines at a concentration of 0. 1 mg/ml with a
Burdick and Jackson column and HPLC conditions of 10% acetonitrile: 90% (1%) acetic
acid, flow rate of 1.0 ml/min, column temperature of25C and a UV wavelength of254
nm. Compounds are as labeled.
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and diameter, as well as particle size, shape, and distribution. The initial column used, was
the Burdick and Jackson OD5 C18 bonded phase with a column length of25 cm an inner
diameter of0.46 cm, and a packing of 5 pm. The inability to improve separation and
especially peak shapes on the B&J column is assumed to be caused by the irregular-shaped
particles of the packing material within the column. Although the B&J column does have
particles ofa size range 4.8-5.2 microns, there is no effort made to regulate particle
shapes. This varies the linear velocity and pathway components within the van Deemter
equation. The net result of the multiple pathways is broad irreproducible peaks. Also the
compounds we are examining tended to adsorb to the surface of the column because of
the irregular particle shapes, which caused the peaks to tail and be ill-defined. This lack of
quality control of solid-support particle shapes also led to variability when columns were
changed. Therefore, a column packed with a more uniform particle shape was purchased,
a Phenomenex Luna column. The Luna column consists ofa C8 bonded phase with a
column length of 15 cm an inner diameter of0.46 cm, and packing of 5 pm This type of
column is packed with spherical shaped particles, which provide more uniformity in the
reproducibility from one packing to another. The change from a Cl 8 to a C8 column was
also varied in hopes of reducing the retention times of the methylxanthines thus providing
a shorter analysis time. In addition to its higher quality, the Luna column provided better
resolution, enhanced peak definition as well as shorter retention times which is as expected
with the shorter length and lower MW stationary phase (Figure 15). Through calculations
you can see the comparison of the value ofN for the Luna column (N) vs. the B&J
column (N): 2274.23 to 788.81, respectively. Althoughmuch improvement was obtained
29















HPLC analysis ofa theobromine, theophylline, and caffeine solution at a concentration of
0. 1 mg/ml with a Phenomenex Luna column and HPLC conditions of65% methanol: 35
(1%) acetic acid, flow rate of 1 .0 ml/min, column temperature of25C and a UV
wavelength of254 nm. Compounds are as labeled.
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using the Luna column, after multiple injections and over time a loss in reproducibility was
observed. Specifically, the retention times of the methylxanthines began to vary with loss
ofresolution and peak shape. The data suggest that with our experimental conditions, the
bonded phase began to break down, leaving silica sites to interact with the solute. In
analytical chemistry consistent reproducible results are extremely important thus a more
chemically resistant column was needed. Through the literature another bonded phase
column was described that apparently could withstand more acidic conditions than the
Luna, an HP Zorbax column. This column consisted ofa C18 stable bonded phase with a
column length of25 cm an inner diameter of0.46 cm and packing of 5 pm. Although
the Zorbax column was very similar to the Luna column in particle shape, it is the binding
of the stationary phase to the solid support that allowed the use ofmore rigorous
conditions. The coating, Rx-SIL, sterically protects the bonded phase allowing it to
remain stable even at extremely low pH. Upon use, the Zorbax column was very efficient
with remarkable reproducibility (Figure 16). Since it provided stability, well-resolved
methylxanthine peaks, and enhanced peak definition; the Zorbax column was determined
as the column of choice.
The next phase of the methods development was to "fine
tune"
the separation of
the methylxanthines by varying other experimental parameters: mobile phase composition,
temperature, and flow rate. The goal is to have maximum resolution in the minimum
timeframe possible. While one usually only changes one variable at a time, in some
instances it was necessary to vary two or more of the above. In reversed phase
chromatography, varying mobile phase goes from a low elution strength to a high elution
strength. In this manner even the weakly bound materials will initially bind to the column
31
Figure 16. Chromatogram of theobromine, theophylline, and caffeine standard solution.
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HPLC analysis ofa theobromine, theophylline, and caffeine solution at a concentration of
0.1 mg/ml with a Hewlett Packard Zorbax column and HPLC conditions of21%
methanol: 79% (2%) acetic acid, flow rate of 1.0 ml/min, column temperature of35C and
aUV wavelength of280 nm. Compounds are as labeled.
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for short periods of time. It is after the evaluation of the results from the low elution
strength that it is slowly varied to higher values either through
step-function or gradient
conditions. The higher elution strength is accomplished by increasing the hydrophobicity
of the solvent mixture. In other words, the polarity of the solvent system is decreased
over time via a gradient. In this study since we were only concerned with water-soluble
materials the elution strength was lowered by slowly increasing the percentage of the
aqueous acetic acid component until desired resolution and plate count was achieved. As
the amount ofaqueous component (1% acetic acid) increased, the more resolved and the
more defined the methylxanthine peaks appear, Figures 17-18. In Figure 18 the peaks are
completely resolved, however it was found that when the ginseng samples were analyzed
under these conditions other materials in the sample interfered with the methylxanthine
peaks. It was through this pattern of slowly increasing the aqueous component that the
final mobile phase composition was determined to be 21% methanol: 79% (2%) acetic
acid (Refer to Figure 16).
In chromatographic separations raising column temperature decreases retention
time, decreases resolution, and most importantly sharpens peaks. First the column
temperature was raised from 25C to 30C, Figure 19 shows the results ofwell-resolved
standards but the caffeine peak is not as sharp as it should be. Again the column
temperature was raised but this time from 30C to 40C. Increasing the temperature to
40C caused the methylxanthines to elute faster from the column and the caffeine peak is
slightly sharper as seen in Figure 20. As expected raising the column temperature resulted
in a shorter analysis time, reduced selectivity of the peaks, and sharper peaks. Although
shorter retention times were obtained from these conditions, desirable separation of the
33
Figure 17. Chromatogram oftheobromine, theophylline, and caffeine standard solution.
HPLC analysis ofa theobromine, theophylline, and caffeine solution at a concentration of
0.1 mg/ml with a Hewlett Packard Zorbax column and HPLC conditions of40%
methanol: 60% (1%) acetic acid, flow rate of 1 .0 ml/min, column temperature of25C and
aUV wavelength of254 nm. Compounds are as labeled.
Figure 18. Chromatogram oftheobromine, theophylline, and caffeine standard solution.
HPLC analysis ofa theobromine, theophylline, and caffeine solution at a concentration of
0. 1 mg/ml with a Hewlett Packard Zorbax column and HPLC conditions of30%
methanol: 70% (1%) acetic acid, flow rate of 1.0 ml/min, column temperature of25C and
a UV wavelength of254 nm. Compounds are as labeled.
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Figure 19. Chromatogram oftheobromine, theophylline, and caffeine standard solution
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HPLC analysis ofa theobromine, theophylline, and caffeine solution at a concentration of
0. 1 mg/ml with a Hewlett Packard Zorbax column and HPLC conditions of30%
methanol: 70% (1%) acetic acid, flow rate of 1.0 ml/min, column temperature of30C and
aUV wavelength of254 nm Compounds are as labeled.
Figure 20. Chromatogram of theobromine, theophylline, and caffeine standard solution
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HPLC analysis oftheobromine, theophylline, and caffeine at a concentration of0.1 mg/ml
with a Hewlett Packard Zorbax column and HPLC conditions of30% methanol: 70%
(1%) acetic acid, flow rate of 1 .0 ml/min, column temperature of40C and aUV
wavelength of254 nm. Compounds are as labeled.
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methylxanthine peaks from the many components in the ginseng supplements could not be
attained when applying these conditions. Taking into consideration the results determined
from the column temperature ofboth 30C and 40C, the final column temperature setting
was determined at 35C (Figure 16). Note the column temperature was determined when
the mobile phase composition was at 30% methanol: 70% (2%) acetic acid.
Flow rate is an important factor in the separation of compounds. When doing a
"quick and
dirty"
analysis, resolution is not usually top priority. Therefore, a faster flow
rate can be applied to the analysis. This generally results in a quicker analysis time since it
will elute at a faster pace the compound(s) that bind more strongly to the stationary phase.
Other times, resolution ofcompounds is an important part of the analysis. Sometimes the
peaks are difficult to separate thus; the flow rate can be reduced. This often results in
band broadening since the compound(s) will be retained longer on the column. Taking
these facts into consideration, perhaps the peaks could be resolved to a greater extent,
which in turn would result in a shorter analysis time. In order to resolve the peaks to a
greater extent the flow rate was reduced from 1.0 ml/min to 0.5 ml/min as shown in Figure
21 . As a result, the methylxanthines were well resolved however most exhibit band
broadening as well as extensive peak tailing. In Figure 22, the flow rate was set to 2.0
ml/min, although this improved peak definition, the methylxanthines could not be resolved
from other components within the ginseng supplements. Consequently a flow rate of 1 .0
ml/min was determined to be most efficient. Note the flow rate was determined using the
Phenomenex Luna column. The detection system for the analysis has to exhibit a linear
response over a wide range ofpossible concentrations. The choice for materials similar to
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Figure 21. Chromatogram ofvarious methylxanthine standards.
HPLC analysis ofvarious methylxanthines at a concentration of0.01 mg/ml with a
Phenomenex Luna column and HPLC conditions of65% methanol: 35% (1%) acetic acid,
flow rate of0.5 ml/min, column temperature of25C and aUV wavelength of254 nm
Compounds are as labeled.



















- \r 1L. V
0 2 5 5 7 5 10 12 5 Mr
HPLC analysis oftheobromine, theophylline, and caffeine at a concentration of0. 1 mg/ml
with a Phenomenex Luna column and HPLC conditions of50% methanol: 50% (1%)
acetic acid, flow rate of2.0 ml/min, column temperature of25C and a UV wavelength of
254 ran. Compounds are as labeled.
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methylxanthines is an Ultraviolet-visible absorption detection system. To choose a
wavelength for detection the first step is to make samples and use a
UV-Vis
spectrophotometer. In this case, a Hewlett Packard model 8453 UV-Vis photodiode array
spectrometer was used and the Xmax for caffeine, theophylline and theobromine are 280
nm, 274 nm, and 274 nm, respectively.
Gathering all the information on the different parameters together and applying
them to the HPLC instrument, the final conditions for the best analysis of the ginseng
supplements were as follows: Zorbax C18 SB column, mobile phase composition of 79%
(2%) acetic acid: 21% methanol, column temperature of35C, flow rate of 1.0 ml/min,
and UV wavelength of280 nm. Figure 16 shows the chromatogram of the three
methylxanthines with the final conditions.
It is important in HPLC analysis to verily the accuracy of the column. Through
time the column packing can deteriorate which would reduce the number of theoretical
plates. This in turn will affect the resolution of the peaks and reproducibility is diminished.
In order to determine the physical condition of the column a calibration check must be
established and performed daily. It was in this manner that the loss ofplate number was
found for the Luna column. Calibration and check curves can be constructed by analyzing
a standard sample at different concentration levels. A response is considered acceptable if
the plot of the analytical response versus the concentration of the analyte in the sample is
linear. Calibration curves were obtained for the Zorbax column for injection volumes of
both 20 pL and 5 pL (Figures 23 and 24). As shown linearity was achieved for each
methylxanthine. After least squares analysis, the equation of the line obtained from the
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For complete results of the methylxanthines in the ginseng supplements refer to Table 6.
In order to determine the linear detection limits of the methylxanthines in the ginseng
supplements, the analysis of samples after serial dilutions was performed (see Figures 25
and 26). As shown the lowest possible level of linear detection was found to be at 0.001
mg/ml for theobromine, theophylline, and caffeine.
After the conditions for analysis are established for a series of standards, real
samples must be analyzed so that any/all matrix effects can be evaluated. In order to
determine if there were any significant matrix effects within the ginseng extracts on the
methylxanthines chromatographic response, internal standards were added to the ginseng
supplement. Then the response from the internal standards was evaluated via standard
addition analysis and the initial concentration of the component was determined (Figure
27). From the internal vs. external standard analyses it was found that the results
correlated within 2%. The following chromatograms are examples of an internal
standard addition to a ginseng supplement. Figure 28 represents the NGE ginseng
supplement alone followed by Figure 29, which is the NGE sample with theophylline as an
internal standard. Figures 30-34 represents the ZKG ginseng supplement as caffeine is
slowly being added as an internal standard addition. Refer to Figure 27 for the standard
addition curve for the ZKG sample.
In depth identification ofa compound within a sample can be determined through
several techniques. At this point it was important to verify the identity of the
methylxanthines found in the various ginseng supplements. This was done using two
different techniques. The first technique was through GC-MS. Figure 35 shows the
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Mass of caffeine in
mg/tablet
ME/45 0.040 0.050 53
CSE/58 0.10 0.030 0.040
BF/43 16 0.030 0.030
PMU/67 0.030 0.040 39
EF/56 0.020 k -k 0.080
LF/57 0.030 0.10 0.040
ZGK/30 3.6 0.040 22
CRG/61 0.45 0.050 2.3
KyG/66 0.050 0.010 0.010
GPM/40 14 0.020 0.020
HP/64 0.12 0.10 0.10
SGR/54 0.030 0.010 0.10
KGR/55 0.10 0.010 0.020
SJWE/62 ** 0.21 0.14
NGE/68 0.030 0.020 0.040
GGK/44 0.040 0.030 0.86
SJP/63 1.9 0.24 0.16
AG/59 0.050 0.080 0.10
GGKC/46 0.040 0.020 0.010
GK/65 0.030 0.070 **
SVSGR/47 0.030 0.010 0.010
CC/51 0.15 0.040 0.030
WSGR/48 0.10 0.020 0.10
KWGR/49 0.10 0.12 0.050
DQ/69 0.040 0.10 0.16
WHSG/50 ** 0.84 **
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Figure 27. Internal Standard addition curve of caffeine to the ZKG ginseng supplement.
Internal Standard Addition of

















HPLC analysis ofthe methylxanthines was done with a Hewlett Packard Zorbax column
and HPLC conditions of21% methanol: 79% (2%) acetic acid, flow rate of 1.0 ml/min,
column temperature of35C and a UV wavelength of280 nm.
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HPLC analysis ofNGE ginseng supplement at a concentration of53.64 mg/ml with the
Zorbax column and the following conditions: mobile phase composition of21% methanol:
79% (2%) acetic acid, flow rate of 1 .0 ml/min, column temperature of35C, and UV
wavelength of280 nm Compounds are as labeled.
Figure 29. Chromatogram ofthe NGE Sample
"spiked"
with Theophylline.
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HPLC analysis ofNGE ginseng supplement at a concentration of53.64 mg/ml with
theophylline as an internal standard at a concentration of0. 1 mg/ml. The Zorbax column
and the following conditions were used: mobile phase composition of21% methanol: 79%
(2%) acetic acid, flow rate of 1.0 ml/min, column temperature of35C, and UV
wavelength of280 nm. Compounds are as labeled.
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Figure 30. Chromatogram ofthe ZKG Ginseng Supplement.
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HPLC analysis ofZKG ginseng supplement at a concentration of49.34 mg/ml with the
Zorbax column and the following conditions: mobile phase composition of21% methanol:
79% (2%) acetic acid, flow rate of 1 .0 ml/min, column temperature of35C, and UV
wavelength of280 nm. Compounds are as labeled.
Figures 31-34. Chromatograms ofthe ZKG Sample at various Standard Addition
Levels ofCaffeine.
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HPLC analysis ofZKG ginseng supplement at a concentration of49.34 mg/ml with an
internal standard addition ofcaffeine at a concentration of0.5 mg/mL The Zorbax column
and the following conditions were used: mobile phase composition of21% methanol: 79%
(2%) acetic acid, flow rate of 1.0 ml/min, column temperature of35C, and UV
wavelength of280 nm. Compounds are as labeled.
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overall scan of the sample and the identification of the peak as caffeine. The second
method used for identification of the methylxanthines was LC-MS. Figure 36 shows the
HPLC chromatogram and the MS spectrum of the ZKG ginseng supplement. The
methylxanthines of interest were identified as theobromine and caffeine.
Reproducibility is an extremely important factor in the analysis of compounds.
Therefore each ginseng supplement was analyzed at least twice. It was also of interest to
see if there was a difference between tablets of the same brand ofginseng as well as tablets
ofthe same brand but which had a different lot number. In order to determine if there was
a difference between tablets of the same brand, 3 tablets were uniformly prepared and
analyzed twice under the same conditions in a continuous fashion. As shown in the
following figures, there were no significant differences (Figures 37-39). For example the
area of caffeine/mg/ml sample is very similar for each tablet, 2.53e4/50.09, 2.54e4/49.59,
2.40e4/47.24, respectively. In order to determine if there was a difference between tablets
of the same brand but which had different lot numbers, one tablet from each bottle was
uniformly prepared and analyzed under the same conditions. Again no significant
differences were observed (Figures 40 and 41).
The following figures are a few examples ofginseng supplements in order to view
the differences between the different samples (Figures 42-45). As shown each ginseng
supplement varies in concentration and intensity in its components of saponins and
methylxanthines. All chromatograms ofeach ginseng supplement can be seen in
Appendix A.
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Figure 36. LC-MS Analysis of the ZKG Ginseng Supplement.
(analysis performed by Dr. JoeMagee, Medeva Corp.)
14 mn
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HPLC analysis ofZKG ginseng supplement at a
concentration of49.04 mg/ml with the
Zorbax column and the following conditions: mobile phase composition of
21% methanol:
79% (2%) acetic acid, flow rate of 1 .0 ml/min,
column temperature of35C, and UV
wavelength of280 nm.
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Figure 37. Chromatogram ofTablet 1 ofthe ZKG Ginseng Supplement at a
concentration of50.09 mg/ml.
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HPLC analysis was obtained with the Zorbax column and the following conditions: mobile
phase composition of21% methanol: 79% (2%) acetic acid, flow rate of 1.0 ml/min,
column temperature of35C, and UV wavelength of280 nm.
Figure 38. Chromatogram ofTablet 2 ofthe ZKG Ginseng Supplement at a
concentration of49.59 mg/ml.
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HPLC analysis was obtained with the Zorbax column and the following conditions: mobile
phase composition of21% methanol: 79% (2%) acetic acid, flow rate of 1.0 ml/min,
column temperature of35C, and UV wavelength of280 nm.
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Figure 39. Chromatogram ofTablet 3 ofthe ZKG Ginseng Supplement at a
concentration of47.24 mg/ml.
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HPLC analysis was obtained with the Zorbax column and the following conditions: mobile
phase composition of21% methanol: 79% (2%) acetic acid, flow rate of 1.0 ml/min,
column temperature of35C, and UV wavelength of280 nm
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Figure 40. Chromatogram ofthe GPM Ginseng Supplement lot # 1433 at a
concentration of48.35 mg/ml.
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Figure 41. Chromatogram ofthe GPM Ginseng Supplement lot # 2816 at a
concentration of49.42 mg/ml.
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HPLC analysis was obtained with the Zorbax column and the following conditions: mobile
phase composition of21% methanol: 79% (2%) acetic acid, flow rate of 1.0 ml/min,
column temperature of35C, and UV wavelength of280 nm
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Figure 42. Chromatogram ofPure Ginseng Root Hairs at a concentration of
30.10 mg/ml
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Figure 43. Chromatogram ofBF Ginseng Supplement at a concentration of50.20 mg/ml
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HPLC analysis was obtained with the Zorbax column and the following conditions: mobile
phase composition of21% methanol: 79% (2%) acetic acid, flow rate of 1.0 ml/min,
column temperature of35C, and UV wavelength of280 nm.
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Figure 44. Chromatogram ofGGK Ginseng Supplement at a concentration of
48.38 mg/ml
























Figure 45. Chromatogram ofME Ginseng Supplement at a concentration of
29.18 mg/ml
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HPLC analysiswas obtained with the Zorbax column and the following conditions: mobile
phase composition of21% methanol: 79% (2%) acetic acid, flow rate of 1.0 ml/min,
column temperature of35C, and UV wavelength of280 nm
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IV. CONCLUSION
The main objective of this study was to develop a method that would provide a
means ofdetermining the amount ofmethylxanthines, (theobromine, theophylline, and
caffeine), within various ginseng supplements. This goal was successfully met using
reversed-phase High Performance Liquid Chromatography with the following conditions:
mobile phase composition of21% methanol: 79% (2%) acetic acid, flow rate of 1.0
ml/min, column temperature of35C, and a UV detectionwavelength of280 nm. The
column used was a Hewlett Packard Zorbax SB-C1 8. The samples were injected in 5-20
(il aliquots depending on concentration. These conditions, when applied to the ginseng
supplements, produced well-resolved methylxanthine peaks, which were identified by
spiking sample aliquots with standards, with GC-MS and with LC-MS. Using calibration
curves, the amount ofeachmethylxanthine contained in all the ginseng supplements was
determined. The reproducibility ofeach supplement was very consistent and fell within
2%.
It was determined that the identity and concentration of the methylxanthines of
interest varywith the type ofginseng (Asian, American, or Siberian) as well as the
manufacturer. The levels ofmethylxanthines in the various supplements range from 0-1
mg/dose to 15-50 mg/dose. With the recommended daily dosages listed on the
manufacturer's bottles the higher end dose would be equivalent to drinking a
"pot"
(8-10 cups) ofcaffeinated coffee per day. With this amount of
caffeine within the
supplements, it is apparent that some of the
"energy"
effects attributed to ginseng may be
caused by the presence ofmethylxanthines. It is also important to note that some
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individuals have a low tolerance to caffeine. Therefore the effect would depend upon the
dosage, supplements with small doses would in fact increase energy, while the higher
concentrated supplements could cause the consumer ingesting these some physiological
discomfort such as nausea, intestinal pain, and maybe even vomiting. This presence of
methylxanthines may be due to natural production by the plant and/or by the actual
addition ofmethylxanthines to the ginseng preparations by the manufacturer. In either
case, the presence ofmethylxanthines in these supplements has been brought to the
consumer's attention through an article in the Democrat and Chronicle last fall.
An area ofcontinuing research in our laboratory is to determine if the levels of
methylxanthines in the supplements are natural or additive. It will be necessary to grow
our own ginseng plants and submit them to different types of stress. In the case ofother
plants, part of the plant's defense mechanism to external predators/stress is to increase
production ofmethylxanthines. Initially we plan to start by stressing the plant with arid
and moist conditions while simultaneously varying the amount ofdirect sunlight. After
these preliminary investigations various plants will be subject to various diseases and
parasites. An HPLC analysis would then be performed on the plant to determine if the
stresses would cause an increase or a decrease in methylxanthine levels.
A final area ofgreat interest would be the evaluation ofherbal supplements for
various salicylates and ephedrine-like compounds. We would emphasize our analysis to
those supplements, which promise clarity in thought, and over all long-term well being.
These two claims could be the result of low doses ofephedrine and aspirin, respectively.
Preliminary studies on the gingko supplements, which claim to increase brain function,
have been completed. The initial conditions determined thus far consist ofa gradient
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elution method. For the first six minutes, the mobile phase composition is set at 50%
(2%) acetic acid and 50% methanol. At six minutes, the gradient begins and, at ten
minutes, a final mobile phase composition of 100% methanol is reached. The flow rate is
1 .0 ml/min, column temperature of25C, and a wavelength ofdetection at 254 nm. With
these conditions we found what appears to be ephedrine within the Gingko supplements.
Further analysis such as LC-MS, and internal standard addition need be completely in
order to accurately identify the peak as being ephedrine and to determine the amount the




The following ginseng supplements have all been analyzed with the Hewlett
Packard Zorbax column and the following conditions: mobile phase composition of21%
methanol: 79% (2%) acetic acid, flow rate of 1 .0 ml/min, column temperature of35C,
andUV wavelength of280 nm
Figure 46. Chromatogram ofthe GGKC Ginseng Supplement at a concentration of
46.81 mg/mi
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Figure 47. Chromatogram ofthe SVSGR Ginseng Supplement at a concentration of
40.85 mg/mL
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Figure 48. Chromatogram oftheWSGR Ginseng Supplement at a concentration of
41.93 mg/ml.
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Figure 49. Chromatogram ofthe KWGR Ginseng Supplement at a concentration of
56.71 mg/ml.
































7.5 10 12.5 15 min
61
Figure 50. Chromatogram ofthe WHSG Ginseng Supplement at a concentration of
50.40 mg/ml.
Figure 51. Chromatogram ofthe CC Ginseng Supplement at a concentration of
51.83 mg/mL
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Figure 52. Chromatogram ofthe HEP Ginseng Supplement at a concentration of
57.46 mg/ml.














Figure 53. Chromatogram ofthe SKG Ginseng Supplement at a concentration of
24.22 mg/mL
VWD1 A, Wavelength=280 nm, TT (980805AM 12-2001 .D)
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Figure 54. Chromatogram ofthe SGR Ginseng Supplement at a concentration of
41.98 mg/ml.














Figure 55. Chromatogram ofthe KGR Ginseng Supplement at a concentration of
47.63 mg/mL







































Figure 56. Chromatogram ofthe EF Ginseng Supplement at a concentration of
48.38 mg/ml.
Figure 57. Chromatogram of the LF Ginseng Supplement at a concentration of
62.21 mg/ml.
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Figure 58. Chromatogram ofthe CSE Ginseng Supplement at a concentration of
42.90 mg/ml.
mAU
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Figure 59. Chromatogram of the AG Ginseng Supplement at a concentration of
51.34 mg/ml.

















Figure 60. Chromatogram ofthe KG Ginseng Supplement at a concentration of
53.04 mg/ml.
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Figure 61. Chromatogram ofthe CRG Ginseng Supplement at a concentration of
50.50 mg/ml.
mAU
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Figure 62. Chromatogram ofthe SJWE Ginseng Supplement at a concentration of
57.18 mg/ml.











Figure 63. Chromatogram ofthe SJP Ginseng Supplement at a concentration of
45.84 mg/ml.
mAU

























Figure 64. Chromatogram ofthe HP Ginseng Supplement at a concentration of
49.01 mg/ml.
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Figure 65. Chromatogram ofthe GK Ginseng Supplement at a concentration of
49.23 mg/ml.


















Figure 66. Chromatogram ofthe KyG Ginseng Supplement at a concentration of
45.16 mg/ml.

































Figure 67. Chromatogram ofthe PMU Ginseng Supplement at a concentration of
32.55 mg/ml.


































Figure 68. Chromatogram oftheNGE Ginseng Supplement at a concentration of
54.61 mg/ml.
15 min
Figure 69. Chromatogram ofthe DQ Ginseng Supplement at a concentration of
56.19 mg/ml.
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Figure 71. Chromatogram ofthe NMG Ginseng Supplement at a concentration of
37.50 mg/ml.


















Figure 72. Chromatogramofthe NASJW Ginseng Supplement at a concentration of
50.68 mg/ml.
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Figure 74. Chromatogram ofthe ZAG Ginseng Supplement at a concentration of
5 1 .34 mg/ml.
















Figure 75. Chromatogram ofthe ZSG Ginseng Supplement at a concentration of
50.55 mg/ml.
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Figure 76. Chromatogram ofthe HASG Ginseng Supplement at a concentration of
50.04 mg/ml.
VWD1 A, Wavelength=280 nm, TT (980820AM 02-0201.D)
15 min
Figure 77. Chromatogram ofthe GGTGR Ginseng Supplement at a concentration of
62.08 mg/ml.
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Figure 78. Chromatogram ofthe HPMG Ginseng Supplement at a concentration of
46.91 mg/ml.
mAU














Figure 79. Chromatogram ofthe SHG Ginseng Supplement at a concentration of
52.98 mg/ml.
VWD1 A, Wavelength=280 nm. TT (980914AM02-0201.D)
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Figure 80. Chromatogram ofthe Ex Ginseng Supplement at a concentration of
27.58 mg/ml.
VWD1 A, Wavelength=280 nm, TT (MAYWK4\5-300018.D)
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APPENDIX B
The following gingko samples have been analyzed with the conditions determined thus fer,
which consist ofa gradient elutionmethod. For the first six minutes, the mobile phase
composition is set at 50% (2%) acetic acid and 50% methanol At six minutes, the
gradient begins and, at tenminutes, a finalmobile phase composition of 100% methanol is
reached. The flow rate is 1 .0 ml/min, column temperature of25C, and awavelength of
detection at 254 nm
Figure 81. Chromatogram of the Pure Ephedrine standard at a concentration of
0.01 mg/ml.
Figure 82. Chromatogram ofthe NGB Gingko Supplement at a concentration of
56.96 mg/ml.
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Figure 83. Chromatogram ofthe GP Gingko Supplement at a concentration of
59.32 mg/ml.












Figure 84. Chromatogram ofthe GBL Gingko Supplement at a concentration of
29.14 mg/ml.
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